©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
The Involvement of Threonine 160 of Cytochrome b of Rhodobacter sphaeroides Cytochrome bc Complex in Quinone Binding and Interaction with Subunit IV (*)

(Received for publication, July 20, 1995; and in revised form, September 20, 1995)

Michael W. Mather (§) Linda Yu Chang-An Yu (§)

From the Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, Oklahoma 74078

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

The cytochrome b subunit (subunit I) of the ubiquinol-cytochrome c reductase (bc(1) complex) is thought to participate in the formation of two quinone/quinol reaction centers, an oxidizing center (Q(o)) and a reducing center, in accordance with the quinone cycle mechanism. Threonine 160 is a highly conserved residue in a segment of subunit I that was shown to bind quinone and is placed near the putative Q(o) site in current models of the bc(1) complex. Rhodobacter sphaeroides cells expressing bc(1) complexes with Ser or Tyr substituted for Thr grow photosynthetically at a reduced rate, and cells expressing the mutated complexes produce an ``elevated'' level of the bc(1) complex. The Ser substitution also affects the interaction of subunit IV with subunit I. Replacement of Thr by Ser results in about a 70% loss of the activity in the purified complex, whereas substitution by Tyr lowers the activity by more than 80%. Both replacements lower the apparent K for ubiquinol. Electron paramagnetic resonance (EPR) spectroscopy shows that in the Ser substituted complex, the environments of the Rieske iron-sulfur cluster in subunit III and the high potential cytochrome b (b) in subunit I have been modified. The spectra of the Ser and Tyr iron-sulfur clusters have become redox-insensitive, with a line shape resembling that of the native complex in the fully reduced state. The EPR signal of b in the Ser complex is shifted from g = 3.50 to g = 3.52, but otherwise the line shape is very similar to the spectrum of the native complex. Most of these results are consistent with current ideas regarding the structure and function of Q(o) in the bc(1) complex, except for the alteration of the b EPR feature, because this heme is not thought to be located in proximity to Q(o). Immunoblotting analysis showed that the Ser or Tyr substituted complex contained significantly less than a stoichiometric amount of subunit IV. The enzymatic activity of mutated bc(1) complex was found to be activable by the addition of purified subunit IV. These results indicate that Thr plays an important role in the structure and/or function of the bc(1) complex.


INTRODUCTION

The ubiquinol-cytochrome c reductase (or the bc(1) complex) is a key component of the energy-conserving electron transfer chains of mitochondria and many respiratory and photosynthetic bacteria. It catalyzes the oxidation of ubiquinol by cytochrome c and the coupled vectorial translocation of protons to generate a transmembrane pH gradient. Although many aspects of the structure and function of this enzyme complex have been elucidated(1, 2, 3, 4, 5, 6, 7) , the nature of the protein structures involved in the binding and reactions of ubiquinone and ubiquinol remain an active area of inquiry, and the identification of the residues involved in subunit interaction is in the initial stages.

The cytochrome bc(1) complex from the purple photosynthetic bacterium Rhodobacter sphaeroides has been purified and characterized in several laboratories(8, 9, 10, 11, 12, 13) . The purified complex contains four protein subunits with five redox cofactors: two b-type cytochromes (b and b), one c-type cytochrome (cytochrome c(1)), one high potential iron-sulfur cluster (the Rieske [2Fe-2S]), and at least one ubiquinone (Q). (^1)This bc(1) complex is functionally analogous to mitochondrial ubiquinol-cytochrome c reductase, and the three largest subunits are homologous to their mammalian counterparts (14) . The degree of sequence similarity is particularly striking among the cytochrome b polypeptides from a wide range of species (2) .

The cytochrome b polypeptide contains the two b hemes and participates in the ubiquinol oxidation and ubiquinone reduction reactions of the Q cycle(6) . He et al.(15) have identified two regions of the bovine cytochrome b subunit that may participate in quinone binding using specific labeling with photoreactive quinone analogs. We have created a number of relatively conservative amino acid replacements in the region of the R. sphaeroides protein that corresponds to the first of these putative quinone-binding regions in the bovine cytochrome b. While screening the chromatophore membranes isolated from photosynthetically grown R. sphaeroides cells expressing the various mutated forms of cytochrome b, we noted that the substitution of a serine for threonine at position 160 resulted in the loss of about two-thirds of the ubiquinol-cytochrome c reductase activity in the membranes relative to membranes from control cells. Combined with the fact that this threonine residue is one of the most conserved amino acids in the primary structure of cytochrome b, this result may indicate that Thr is an important residue involved in the structure and function of the bc(1) complex. Here we report the purification and further characterization of the complexes containing conservative substitutions at position 160 of cytochrome b, which affect the activity of the enzyme and the properties of redox centers residing in separate subunits. In general, the results are consistent with current models, placing this region of cytochrome b at or near the quinol-oxidizing center and the intersubunit interface with the iron-sulfur subunit. However, the substitution of serine for threonine 160 also has an effect on cytochrome b, which is not generally thought to interact directly with the quinol-oxidizing center. Thr may also play a role in the proper interaction of subunit IV and cytochrome b.


EXPERIMENTAL PROCEDURES

Materials

Dodecyl maltoside was purchased from Anatrace. All other chemicals were of reagent grade or of the highest quality commercially available. Plasmids pUC4K (16) and pSL1180 (17) were obtained from Pharmacia Biotech Inc. Restriction endonucleases and DNA modifying enzymes were purchased from Promega, Life Technologies, New England Biolabs, U. S. Biochemical Corp., Perkin-Elmer, and Pharmacia. Escherichia coli strains were purchased from BRL Life Technologies (DH5alpha), Invitrogen (INValphaF`), and Promega (BMH-71-18 mutS). E. coli S17-1(20) , R. sphaeroides BC17(21) , and the plasmid pRK415 (18) were generously provided by Dr. R. B. Gennis (University of Illinois). pSup5Tp (19) was a gift from Dr. T. Donahue (University of Wisconsin). Wild-type R. sphaeroides NCIB8253 was generously provided by Dr. R. Niederman (Rutgers University).

Growth of Bacteria

E. coli were grown at 37 °C on LB medium. Extra rich media, e.g. TYP(22) , were used in procedures for the rescue of single-stranded DNA or the purification of low copy number plasmids(23) . Plasmid-bearing R. sphaeroides BC17 cells were grown at 30 °C on an enriched Sistrom's medium (24) containing 5 mM glutamate and 0.2% casamino acids. The pH of the medium was adjusted to 7.1 with a solution of 6 M NaOH and 2 M KOH to increase the sodium ion content of the medium to a more optimal level(24) . Photosynthetic cultures of R. sphaeroides were grown essentially as described(25) . Cells harboring mutated fbc genes on the pRK415-derived plasmids described below were grown photosynthetically for one or two serial passages only to minimize any pressure for reversion. The inoculation volume used for photosynthetic cultures was always at least 5% of the total volume. Antibiotics were added at the following concentrations: ampicillin, 100-125 mg/liter; tetracyline, 10-15 mg/liter for E. coli and 0.75-1.0 mg/liter for R. sphaeroides; kanamycin sulfate, 30-50 mg/liter for E. coli and 20-25 mg/liter for R. sphaeroides; trimethoprim, 85-100 mg/liter for E. coli and 25-30 mg/liter for R. sphaeroides.

Construction of Mutation(s)

Mutations were constructed by site-directed mutagenesis using the Altered-Sites system from Promega, and oligonucleotides were synthesized at the OSU Recombinant DNA/Protein Core Facility. The successfully employed oligonucleotides were CTGGGGCGCCAGCGTGATCAC for the Thr Ser mutation and CCTTCTGGGGCGCCTACGTGATCACCGGCCT for the Thr Tyr mutation. The template DNA fragment for mutagenesis was obtained from a previously cloned 6.7-kilobase pair BamHI fragment, which was isolated from R. sphaeroides NCIB 8253 (^2)and contains the fbcFBC operon encoding the three largest subunits of the cytochrome bc(1) complex. The 3.5-kilobase pair NcoI-BstXI DNA fragment containing the fbcFBC operon was subcloned from the BamHI clone into pALTER-1 (Promega; previously designated pSELECT-1). In order to facilitate sequence verification and transfer into the expression vector following mutagenesis, the template was modified to reduce the size of the DNA fragment containing the target sites for mutagenesis. For this purpose we introduced a silent mutation creating a PinAI site (at position 579 in the fbcB gene) and eliminated a BstEII site present outside of the coding regions in the cloned R. sphaeroides DNA fragment, so that the target region for mutagenesis is contained in a 200-base pair fragment flanked by unique BstEII and PinAI sites (Fig. 1). We also introduced a unique XbaI site between the fbcB and fbcC genes. The nucleotide sequence from just upstream of the BstEII site through the PinAI site was determined and found to be identical to the published sequence of the fbcB gene from R. sphaeroides Ga(21) , except for the single base changed in creating the PinAI site. This engineered fbc operon was subcloned into the expression vector (see below), conjugated into R. sphaeroides BC17 (a strain from which most of the fbcFBC operon has been deleted(21) ), and found to support the same rate of photosynthetic growth as the original 3.5-kilobase pair fbc clone.


Figure 1: Plasmids constructed for mutagenesis, transfer, and expression of the R. sphaeroides fbc operons containing mutated fbcB genes encoding altered cytochromes b. A, pSELNB3503 was derived from pALTER-1 (pSELECT-1) by insertion of a 3.5-kilobase pair R. sphaeroides DNA fragment containing the fbc operon (see ``Experimental Procedures''). fbcF, fbcB, and fbcC denote the genes encoding the iron-sulfur subunit, the cytochrome b subunit, and the cytochrome c(1) subunits, respectively. The restriction sites marked by asterisks were engineered in vitro to facilitate verification and transfer of the segment of the fbcB gene containing the mutations (see text). Only selected restriction sites are shown. B and C, broad-host-range plasmids pRKDNB3503, containing the engineered wild-type fbcFBC operon, and pRKDNB35KmBP were constructed to facilitate subcloning, conjugal transfer to R. sphaeroides, and expression of cytochrome bc(1) complexes containing altered cytochromes b.



Construction of Vectors for the Expression of Mutated Complexes in R. sphaeroides

The gene encoding a trimethoprim-resistant dihydrofolate reductase from R388 (26) (excised from pSup5Tp) and the engineered fbc-containing insert from pSELNB3503 were combined into the multiple cloning site polylinker of pSL1180 by a series of in vitro manipulations. The resulting 4400-base pair fragment containing the dihydrofolate reductase gene and the R. sphaeroides fbc operon were subcloned together into the HindIII and EcoRI sites of the broad host range vector pRK415, producing pRKDNB3503 (Fig. 1B). For the purpose of subcloning the 200-base pair BstEII-PinAI fragments from pSELNB3503 following mutagenesis, pRKDNB35KmBP (Fig. 1C) was constructed by inserting the kanamycin resistance cassette from pUC4K between the BstEII and PinAI sites of pRKDNB3503. Using pRKDNB35KmBP to receive the mutated BstEII-PinAI fragments eliminates the possibility of retaining or recloning the wild-type fragment when attempting to subclone the mutated fragments into the expression vector (27) . Loss of kanamycin resistance was then used to screen for recombinant plasmids. pRKDNB3503 derivatives were conjugated into R. sphaeroides BC17 (21) from E. coli S17-1 (20) using a plate mating procedure essentially as described(28, 29) .

Other Recombinant DNA Techniques

General molecular genetic methods were performed essentially as described in Sambrook et al.(30) . DNA plasmids and restriction fragments were recovered from preparative agarose gels according to Qian and Wilkinson (31) after staining with methylene blue (this avoids exposure to ultraviolet light). Nucleoside sequencing was performed with an Applied Biosystems model 373 automatic DNA sequencer. Sequencing of mutagenized DNA templates was conducted by amplification of a DNA segment including the entire BstEII to PinAI sequence using polymerase chain reaction followed by conversion to single-stranded form by treatment with T7 gene 6 exonuclease as described(32) . The presence of engineered mutations and the absence of other changes in the template region was reconfirmed once for each mutant clone following transfer to and expression in R. sphaeroides BC17 by purifying the expression plasmid from an aliquot of a photosynthetic culture and determining the nucleotide sequence as described above.

Isolation of Chromatophores and Purification of bc1 Complexes

Chromatophores were prepared from frozen cell paste of photosynthetically grown R. sphaeroides BC17 complement and mutant strains by proportionally scaling down the previously described procedure (33) with minor modifications. To prepare chromatophores for preliminary characterization in situ, the initial clarification step by low speed centrifugation was modified by increasing the speed to 38,000 times g and the duration to 45 min (34) in order to reduce the light scattering of the chromatophore suspensions.

The cytochrome bc(1) complexes were purified from chromatophores by a modification of the procedure of McCurley et al.(11) . Dodecyl maltoside was used to solubilize the bc(1) complexes and 20% glycerol was included during the solubilization and loading of the first column (after Andrews et al.(12) ) to help stabilize mutated bc(1) complexes in case they prove to be less stable to the extraction conditions. Chromatophore suspensions were adjusted to about 18 µM cytochrome b by addition of 50 mM Tris-HCl (pH 8.0 at 0 °C) containing 20% glycerol, 1 mM MgSO(4), and 1 mM phenylmethylsulfonyl fluoride. Dodecyl maltoside (10% solution in 50 mM Tris-HCl (pH 8.0 at 0 °C) containing 20% glycerol and 1 mM MgSO(4)) was added to the chromatophore suspension to 0.525 mg/nmol cytochrome b, and the mixture was stirred for 30 min at 0 °C and then centrifuged at 27,000 times g for 30 min. The hard precipitates at the bottom of the centrifuge tubes were discarded, and the loose pellets and supernatants were collected. 4 M NaCl was added to a final concentration of 0.1 M, and the suspension was stirred for 1 h at 0 °C. The mixture was centrifuged at 200,000 times g for 90 min. The supernatants were collected and applied to a DEAE-Biogel A column equilibrated with 50 mM Tris-HCl (pH 8.0 at 0 °C) containing 20% glycerol, 100 mM NaCl, 1 mM MgSO(4), 5 mM NaN(3), and 0.01% dodecyl maltoside (TMGD buffer containing 100 mM NaCl). The column was washed with, in sequence, 3.33 volumes of TMGD buffer containing 100 mM NaCl, 2 volumes of TMD buffer (TMGD buffer without glycerol) containing 150 mM NaCl, and 2 volumes of TMD buffer containing 200 mM NaCl. The crude cytochrome bc(1) complex was eluted from the column with TMD buffer containing 300 mM NaCl. The collected bc(1) complex was diluted with one-half volume of TMD containing 40% glycerol and applied to a DEAE-Sepharose CL-6B column equilibrated with TMD buffer containing 100 mM NaCl. The column was washed with 2 column volumes each of TMD buffer containing 150 mM NaCl, 200 mM NaCl, and 250 mM NaCl. The nearly pure cytochrome bc(1) complex was eluted with TMD buffer containing 375 mM NaCl and concentrated using a Centriprep-10 concentrator to a final concentration of 100 µM cytochrome b or greater. Glycerol was added to about 20%, and the purified complex was stored at -80 °C. The purity of the bc(1) preparations estimated by SDS-PAGE was 90-95%.

Biochemical and Spectroscopic Methods

Ubiquinol-cytochrome c reductase activity was measured at 23 °C by following the reduction of cytochrome c at 550 nm in a Shimadzu UV2101PC spectrophotometer. A millimolar extinction coefficient of 18.5 was used in calculating the reduced cytochrome c concentration. The nonenzymatic reduction of cytochrome c by ubiquinol was determined under the same conditions in the absence of enzyme. Chromatophore preparations were diluted to a concentration of 1.25-7.5 µM cytochrome b, depending on the expected specific activity of the sample, with a solution of 50 mM Tris-HCl (pH 8.0 at 0 °C), 1 mM MgCl(2); bc(1) preparations were diluted with 50 mM Tris-HCl (pH 8.0 at 0 °C), 250 mM NaCl, 1 mM MgCl(2), 10% glycerol, and 0.005% dodecyl maltoside. Chromatophores and bc(1) preparations were assayed by addition of 2-5 µl of suitably diluted samples to a 1.0-ml assay mixture containing 100 mM sodium/potassium phosphate buffer (pH 7.4), 0.3 mM EDTA, 50 µM cytochrome c, and 10 µM 2,3-dimethoxy-5-methyl-6-(10-bromodecyl)-1,4-benzoquinol; 30 µM potassium cyanide was added to assays of chromatophores to inhibit oxidase activity. Protein was determined by the Lowry method (35) with the inclusion of 1% sodium dodecyl sulfate in the samples and standards. For accurate measurement of the protein content of chromatophores, interfering pigments were removed by acetone/methanol extraction as described(36) . Cytochrome b(37) , cytochrome c(1)(38) , ubiquinone(39, 40) , and bacteriochlorophyll (41) were determined according to published methods.

SDS-PAGE was performed according to Laemmli (42) and to Schägger and von Jagow (43) using a Bio-Rad Mini-Protean dual slab vertical cell. Disaggregation of the sample and resolution was best obtained using a freshly prepared solubilization buffer containing 5% SDS, 10 mM EDTA (pH 8.0), 5% 2-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, and 10% glycerol, followed by separation on a 16.5% polyacrylamide gel as described(43) . Samples were incubated for 1-2 h at 30-37 °C immediately prior to loading onto the gel. Chromatophores were extracted with acetone/methanol (36) before solubilization. Western blotting was carried out as described (44) using rabbit antibody raised against purified subunit IV (33) or against purified subunit II (cytochrome c(1))(45) . The polypeptides separated in the SDS-PAGE gel were transferred to a 0.2-µm polyvinylidene difluoride membrane for immunoblotting. Goat anti-rabbit IgG conjugated to alkaline phosphatase or protein A conjugated to horseradish peroxidase was used as the second antibody.

Low temperature EPR spectra were obtained with a Bruker ER 200D spectrometer equipped with an Air Products flow cryostat. Some spectra were recorded at 77 °K using a liquid N(2) Dewar. Instrument setting details are provided in the legends of the relevant figures.


RESULTS

Expression and Purification of Cytochrome bc(1)Complexes Containing Altered Cytochrome b

Expression of cytochrome b with the conservative substitution Thr Ser (T160S) as part of an fbc operon contained on a low copy number plasmid in R. sphaeroides BC17 yields cells capable of photosynthetic growth at a retarded rate (maximal doubling rate about 50-60% of that obtained with the complement strain).The properties of chromatophore membranes isolated from these cells are summarized in Table 1together with the properties of membranes from complement cells expressing the wild-type cytochrome b also encoded by a plasmid-borne gene. The specific ubiquinol-cytochrome c reductase activity of membranes from the mutant cells is significantly reduced (25-40% of the activity found in complement membranes). On the other hand, these membranes also contain an apparently elevated level of the complex, as indicated by the elevated level of cytochrome b, relative to that found in membranes prepared from complement cells (membranes from complement cells already possess two to three times the amount of cytochrome b found in wild-type R. sphaeroides, presumably due to a gene dosage effect; data not shown, but see (21) ). This enhanced level of cytochrome b was found in the membranes of each of three independently isolated mutants containing the T160S alteration.



The mutation Thr Tyr (T160Y) was also subsequently prepared. R. sphaeroides cells expressing this variant of cytochrome b are also able to grow photosynthetically at a reduced rate. The cytochrome b content of membranes from these cells is also elevated relative to membranes from complement cells (Table 1) but to a slightly lesser extent than membranes containing the T160S complex. The specific ubiquinol-cytochrome reductase activity of these membranes was even lower than that of membranes containing the T160S complex, only 10-20% of that found in complement membranes.

The bc(1) complexes were extracted with dodecyl maltoside and purified by a modification of described methods (see ``Experimental Procedures'') from chromatophore membranes of Rs BC17 cells expressing the Thr Ser or Tyr mutations and from membranes of BC17 expressing the cloned wild-type complex (complement cells). The T160S complex is spectrally identical to the complement complex (Fig. 2) but retains the lower activity seen in the chromatophores. The absorbance spectrum of T160Y bc(1) is also similar to that of the complement bc(1), but the ratio of b to c(1) is lower for T160Y. The biochemical properties of the purified enzymes are summarized in Table 2. SDS-PAGE (Fig. 3) shows that the T160S and T160Y complexes contain the same four subunits as the wild-type and complement enzymes, but the T160S complex has a reduced level of subunit IV (estimated by densitometry to be about one half the level present in the complement bc(1) complex). Indeed, addition of purified, recombinant subunit IV to the enzyme caused a 70% increase in the activity of the T160S bc(1) complex (Fig. 4). Addition of subunit IV to the complement bc(1) complex also produced some stimulation of the activity. By comparison, addition of exogenous subunit IV to purified three-subunit complex (completely lacking subunit IV(46) ) resulted in a 5-fold stimulation of the basal specific activity under the conditions used (Fig. 4). Apparently not all of the recombinant subunit IV preparation used was in an active conformation for interaction with depleted bc(1) complexes, because full stimulation of the three-subunit bc(1) required more than three molecules of subunit IV per bc(1) complex. Examination of additional preparations of wild-type, complement, and mutant bc(1) complexes by SDS-PAGE (not shown) indicated that the relative amount of subunit IV present varies somewhat for each preparation, but purified T160S bc(1) had a consistently lower ratio of IV relative to subunits I-III than complement or wild-type complexes.


Figure 2: Reduced minus oxidized optical absorption spectra of purified bc(1) complexes. Ferricyanide-oxidized and dithionite-reduced spectra of bc(1) complexes diluted to 2.5 µM cytochrome b were recorded at room temperature in 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM MgCl(2), 0.01% dodecyl maltoside, and 20% glycerol, and the difference spectra were calculated.






Figure 3: SDS-PAGE of purified bc(1) complexes and Western analysis for subunit IV. Aliquots of mutated, complement, and wild-type bc(1) complexes containing approximately 75 pmol cytochrome b were analyzed on duplicate gels by SDS-PAGE using the tricine buffer system (A). One gel was transferred to a polyvinylidene difluoride membrane and probed with antibody raised against R. sphaeroides subunit IV (B). Lanes 1, bc(1) from wild-type R. sphaeroides; lanes 2, bc(1) from R. sphaeroides BC17 complement strain; lanes 3, prestained molecular mass standards; lanes 4, bc(1) from R. sphaeroides BC17 expressing the T160Y mutation; lanes 5, bc(1) from R. sphaeroides BC17 expressing T160S mutation. The concentration of the sample in lane 1 was overestimated prior to loading on the gel.




Figure 4: Activation of T160S and three-subunit bc(1) complexes by addition of exogenous, recombinant subunit IV. Cytochrome bc(1) complexes of T160S (bullet) and the three-subunit core complex (circle) diluted to 2.5 µM cytochrome b were mixed with varying amounts subunit IV in a total volume of 30-50 µl of 50 mM Tris-HCl (pH 8.0 at 0 °C), 250 mM NaCl, 1 mM MgCl(2), 0.01% dodecyl maltoside, and 10% glycerol and incubated on ice for 1-2 h. 3-µl aliquots were withdrawn for assay of ubiquinol-cytochrome c reductase activity. The amount of subunit IV added was based on determination of the protein content by the method of Lowry(35) . The concentration of bc(1) complex present was redetermined after dilution by optical difference spectroscopy and was based on the cytochrome c(1) content.



In order to examine the relative amount of subunit IV initially present in the membranes of the mutant and complement cells, mutant and complement cells were grown side by side, and chromatophore membranes were prepared at the same time. Examination of these chromatophores by SDS-PAGE and subsequent Western blots developed with antibodies raised against subunit IV indicates that the membranes from the cells expressing T160S cytochrome b contain a significantly lower ratio of subunit IV to cytochrome b when compared with the complement membranes. It was estimated to be about 40% of the ratio found in the complement cells by densitometry corrected for the apparent relative transfer efficiency (see Fig. 5). T160Y membranes contain a modestly lower ratio of subunit IV to cytochrome b (estimated to be 80% of the complement level). Complement membranes, in turn, appear to contain a lower ratio of subunit IV than membranes from wild-type R. sphaeroides (not shown). It thus appears that R. sphaeroides cells overproducing the fbc genes due to the presence of multiple copies of the operon on a plasmid and/or other factors either do not induce a concomitant increase in the levels of subunit IV or have a more rapid turnover of that subunit. This effect is most pronounced in the case of the T160S substitution.


Figure 5: Western analysis of chromatophore membranes from mutated and complement bc(1) complexes. Membrane samples containing 75 pmol (lanes 1-4) or 150 pmol (lanes 6-9) cytochrome b were extracted with acetone/methanol to remove pigments, redissolved in loading buffer containing SDS and 2-mercaptoethanol, and subjected to tricine SDS-PAGE on duplicate gels. One gel was transferred electrophoretically to a polyvinylidene difluoride membrane. The membrane was cut into two pieces so that the upper part contained proteins with a molecular mass greater than about 23 kDa, and the bottom section contained the low molecular mass proteins. The top section of the membrane was probed with antibodies to R. sphaeroides subunit II (cytochrome c(1)) and developed with a horseradish peroxidase system, whereas the bottom section was probed with antibodies to subunit IV and developed with an alkaline phosphatase system. Only the Western analysis of the membrane is shown. Lane 1, chromatophores (75 pmol b) from R. sphaeroides BC17 expressing the T160S mutation; lane 2, chromatophores (75 pmol b) from BC17 expressing the T160Y mutation; lane 3, chromatophores (75 pmol b) from BC17 complement; lane 4, chromatophores (75 pmol b) from DeltaQ strain (46) lacking subunit IV; lane 5, prestained molecular mass standards; lane 6, chromatophores (150 pmol b) from BC17 expressing the T160S mutation; lane 7, chromatophores (150 pmol b) from BC17 expressing the T160Y mutation; lane 8, chromatophores (150 pmol b) from BC17 complement; lane 9, chromatophores (150 pmol b) from DeltaQ strain (46) lacking subunit IV.



Effect of Mutation on the Antimycin-sensitive Radical Associated with the Quinone-reducing Site

The purified bc(1) complexes from complement and T160S-expressing cells were poised in a partially reduced state and examined by EPR spectroscopy to compare the features of the antimycin-sensitive ubisemiquinone radical. Both the mutated and the complement complexes were found to contain a ubisemiquinone radical 7.5 Gauss in width at g = 2.004 (Fig. 6), as previously reported for the wild-type complex(11) . The power saturation behavior of the mutated and complement complexes were examined and found to be virtually identical (Fig. 6, inset). These results indicate that both the complement and mutated bc(1) complexes have an intact quinone reducing center that stabilizes an anionic ubisemiquinone radical.


Figure 6: EPR spectra of the antimycin-sensitive ubisemiquinone radical in the T160S cytochrome bc(1) complex. Oxidized complement and T160S cytochrome bc(1) complexes containing about 300 µM cytochrome b in 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 1 mM MgCl(2), 0.01% dodecyl maltoside, and 20% glycerol were mixed with a fumarate/succinate mixture (40:1) such that the final concentration of succinate was 3 mM and a catalytic amount of bovine succinate-ubiquinone reductase. After recording the spectra over a range of microwave powers, the samples were thawed and a 2-fold excess of antimycin A was added. The EPR spectra of the T160S complex at 0.2 milliwatts in the absence (1) and presence (2) of antimycin are shown together with their difference (1-2; the antimycin-sensitive radical) spectrum. The inset shows the uncorrected power saturation curves of the samples. EPR instrument parameters were a microwave frequency of 9.32 GHz, a modulation amplitude of 4 G, a time constant of 0.05 s, a scan rate of 2.5 G/s, and a temperature of 140 K.



Effect of Mutation on the Rieske Iron-Sulfur Cluster

The EPR parameters of the Rieske [2Fe-2S] cluster are thought to be sensitive to the redox state of the Q pool and the quinone(s) bound at the quinol-oxidizing center (Q(o))(11, 12, 47, 48, 49, 50, 51, 52) . EPR spectra of the T160S and complement bc(1) complexes were recorded under several conditions, some of which are shown in Fig. 7. When cytochrome c(1) and the [2Fe-2S] cluster are reduced by a small excess of ascorbate, the complement bc(1) complex has a spectrum that is essentially the same as that previously reported for the complex from wild-type R. sphaeroides, with resonances at g(z) = 2.02, g(y) = 1.89, and g(x) = 1.81(11, 12) . In contrast, the spectrum of the mutated complex shows a broadened signature with g(x) shifted to 1.76; this change is apparently not due to the partial depletion of subunit IV found in the T160S complex, because three-subunit bc(1) purified from a strain having no subunit IV (46) has an EPR spectrum very similar to that of the wild-type complex with g(x) = 1.81. (^3)Upon partial oxidation of the samples by titration with ferricyanide to an apparent potential of about 210 mV (with cytochrome c(1) (E = 240 mV) one-fourth oxidized), no changes were found in the spectrum of either the mutant or the complement bc(1) complex (not shown). Upon complete reduction by addition of dithionite, the spectrum of the bc(1) complement complex is broadened, with g(x) shifting to 1.76, as previously reported for the wild-type bc(1) complex under fully reduced conditions(11, 12) , whereas the spectrum of the T160S complex remains unchanged with g(x) = 1.76. The altered complex thus has a spectrum closely resembling the ``reduced state'' spectrum of the complement, regardless of the redox state of the ubiquinone pool. The EPR spectra of the T160Y [2Fe-2S] cluster are very similar to those of T160S (not shown).


Figure 7: EPR spectra of the iron-sulfur cluster in T160S and complement bc(1) complexes. A, cytochrome bc(1) complexes (300 µM cytochrome b) were partially reduced by the addition of sodium ascorbate to 1 mM. The samples were incubated on ice for about 20 min and frozen in liquid nitrogen. EPR spectra were recorded at 8 K. The instrument settings were: microwave frequency, 9.27 G; microwave power, 2 milliwatts; modulation amplitude, 6.3 G; time constant, 0.1 s; scan rate, 20 G/s. B, the samples used in A were thawed on ice and reduced by the addition of a small excess of sodium dithionite from a buffered solution. The samples were refrozen, and the EPR spectra were recorded at 10 K. Instrument settings were the same as in A.



Effect of Mutation on the b Cytochromes

Fig. 8shows the EPR spectra of the b cytochromes from the T160S bc(1) complex and from the complement complex, taken after the samples were reduced with sodium ascorbate to eliminate the overlapping signal from cytochrome c(1). The complement bc(1) has features at g = 3.50 and g = 3.75 previously assigned to cytochrome b and b, respectively, in the wild-type bc(1) complex (11) . The g = 4.3 signal is thought to be due to nonspecifically bound iron(III). Similar EPR spectra were also previously reported for the mitochondrial bc(1) complex(53, 54, 55) . In contrast, the cytochrome b signal of the T160S bc(1) complex is shifted to 3.52, whereas the position of the cytochrome b feature is unchanged. The degree of broadness of the signals appears to be virtually unchanged by the mutation, with the g = 3.75 signal being the sharper of the two. As in the case of the [2Fe-2S] spectra, the change observed in the spectrum of the T160S complex is apparently not due to depletion of subunit IV because the three-subunit bc(1) complex showed identical EPR characteristics as those of the wild-type complex.^3


Figure 8: EPR spectra of b cytochromes in T160S and complement bc(1) complexes. The ascorbate-reduced bc(1) complexes were prepared as described in the legend to Fig. 7. The EPR spectra were recorded at 15 K with the following instrument settings: microwave frequency, 9.20 GHz; microwave power, 20 milliwatts; modulation amplitude, 20 G; time constant, 0.1 s; scan rate, 5 G/s.




DISCUSSION

Threonine 160 is a highly conserved residue in the primary sequence of cytochrome b, present in all known mitochondrial and eubacterial cytochromes b, except those from nematodes (2) . Its position in the primary sequence is near residues that are altered in mutations conferring resistance to Q(o) center inhibitors (Gly, Ile, and Thr), and it is contained within a segment of the cytochrome b polypeptide that corresponds to a peptide specifically labeled by azido-quinone in the bc(1) complex from beef heart(15) . Current interpretations of experimental data and modeling efforts place this region in an amphipathic helix, designated as helix-cd, located on the positive side of the membrane and forming part of the Q(o) center of the complex. This region should also be close to cytochrome b(L), which is reduced by semiquinone in the Q(o) center. Indeed, a mutation at the position corresponding to Ile in Rhodobacter exhibits an altered circular dichroism spectrum for cytochrome b of yeast(56) . Furthermore, the Rieske [2Fe-2S] cluster should also be located nearby, although it is bound to a different subunit of the complex, because it is reduced by quinol in the Q(o) center and binds certain Q(o) center inhibitors. As a conserved residue in a perhaps pivotal region of the complex, Thr proves to be a good candidate for investigation using the method of site-directed mutagenesis combined with biochemical and biophysical characterization.

Expression of the T160S mutation in cytochrome b results in a bc(1) complex having a significant loss of activity partially compensated by a small decrease in the apparent K(m). Interestingly, cells expressing this mutated cytochrome b during photosynthetic growth appear to induce an increased level of the three largest subunits of the bc(1) complex. This induction could be a regulatory response of cells expressing the mutated complexes to lowered electron transfer activity or an elevated ``redox poise.'' Alternatively, the effect could be caused by a spontaneous second-site mutation that leads to enhanced expression and is positively selected by photosynthetic growth. The latter possibility is unlikely, however, because three T160S clones independently isolated following mutagenesis all displayed elevated levels of the bc(1) complex during the first round of photosynthetic growth following initial amplification by aerobic growth in the dark. The purified T160S complex contains a significantly reduced amount of subunit IV, relative to the bc(1) complex purified from complemented cells. Addition of recombinant subunit IV to the partially depleted preparations results in an increase in activity; however, the final activity of reconstituted T160S bc(1) complex still remains lower than that of the complement bc(1) complex. Given the apparent low content of subunit IV in the T160S bc(1) preparations, the less than 2-fold activity increase seen upon incubation with added exogenous subunit IV is surprising. One possible explanation is that a large fraction of the purified T160S bc(1) complex is in a conformation that no longer interacts with subunit IV, perhaps due to aggregation or partial denaturation. Another possibility is that the low level of subunit IV found in the T160S membranes in the first place, as well as any conformational changes, in some measure results from a decreased affinity of subunit IV for the modified cytochrome b. The possibility that Thr in cytochrome b is directly or indirectly involved in the binding of subunit IV to the bc(1) complex is currently under investigation. In contrast to the expression levels observed with T160S, membranes isolated from T160Y contain levels of subunit IV more comparable with the complement chromatophores. Possibly this more hydrophobic substitution has an effect on the interaction of subunit IV with cytochrome b different from that of the T160S change.

The EPR spectra of the T160S complex display altered signatures for both the Rieske iron-sulfur center and cytochrome b. Interestingly, the broad g = 3.50 signal attributed to b is shifted to lower field, whereas the g = 3.75 signal due to b appears to be essentially unchanged in the spectra of the mutated complex. This is somewhat surprising, because it is b that is thought to be located near the quinol-oxidizing center and the positive side of the membrane, whereas b resides in the central portion of the membrane or closer to the negative side and the quinone-reducing center of the complex(3, 5, 6) . Thus, the effect of the T160S substitution on the b spectrum would appear to be indicative of a long range interaction between the oxidizing center and b or of a geometry placing the two in closer proximity than current models. It is noted that long-range effects of mutations at other positions in cytochrome b have been previously reported, e.g. the redox midpoint potentials of cytochrome c(1) were affected by substitutions in cytochrome b(27) .

The substitutions at T160 in cytochrome b also affected the EPR signature of the Rieske [2Fe-2S] center, which is located in a separate subunit of the complex. The iron-sulfur subunit is thought to bind in the general vicinity of b on the positive side of the membrane to form part of the quinol-oxidizing center, because the cluster is a primary electron acceptor from the quinol. The particular line shape observed for the [2Fe-2S] cluster is thought to be mediated by the oxidation state of the ubiquinone present in the Q(o) center(11, 12, 50, 51, 52, 53, 57) . When oxidized quinone is present, the EPR signal is sharper than when quinol is present. The change is most apparent in the case of the g(x) resonance, which in the bc(1) from R. sphaeroides is found at g = 1.81 when oxidized ubiquinone is present but shifts to 1.76 and becomes much broader when ubiquinol is present. The substitutions at Thr resulted in a broadened [2Fe-2S] EPR signature with g(x)=1.76, which is unaltered by accessible changes in the redox state of the samples. There was no detectable difference between the EPR spectra of the mutated complexes and the ``reduced state'' spectrum of the complement or wild-type bc(1) complex. The effect of the mutations on the iron-sulfur cluster spectrum suggests that the Thr residue of cytochrome b interacts with the quinol-oxidizing center and/or the [2Fe-2S] cluster. This idea is consistent with current models of the structure and function of this part of the complex.

The effect of the T160 substitutions on the iron-sulfur cluster is also reminiscent of the change observed for the substitution of Leu for Phe (F144L) in the cytochrome b from R. capsulatus(58) . The F144L bc(1) complex in R. capsulatus chromatophores was reported to have a very low turnover rate and a dysfunctional Q(o) center (having less than 10% of the wild-type activity for the ubiquinol to cytochrome b(H) reduction step). The EPR spectrum of F144L was broadened and insensitive to redox state with g(x) assigned a value of 1.765. It was suggested that these properties of the F144L complex resulted from a reduced affinity for quinone and quinol exhibited by the Q(o) center of the mutated complex. In a subsequent study of the effect of the extraction of ubiquinone from chromatophore membranes on the iron-sulfur cluster, Ding et al.(52) found that the g(x) signal became very broad and was located at approximately 1.765 upon depletion of ubiquinone from R. capsulatus chromatophore membranes. These workers were able to distinguish the ``depleted state'' spectrum having g(x) 1.765 from the ``reduced state'' spectrum with g(x) = 1.777 and found that the line shape of the quinone-depleted state was broadened considerably beyond that seen in the presence of either ubiquinone or ubiquinol. With our EPR instrumentation we cannot assign g values with such a high degree of precision given the broadness of the g(x) feature in the reduced and the putative quinone-depleted states. However, there was no significant difference in the width or depth of the g(x) = 1.76 signals of the R. sphaeroides T160S and T160Y bc(1) complexes relative to the spectrum of the complement bc(1) in the reduced state. Thus, the changes in the iron-sulfur cluster EPR spectra resulting from the T160 substitutions in the R. sphaeroides system do not exhibit the extremely broad line shape reported for the quinone-depleted state and are probably not due to a complete absence of quinone and quinol binding to the Q(o) center. The nature of these interactions will be the subject of future investigations. One possibility, which would account for the reduced turnover of the mutant complexes and their ``reduced state'' EPR spectra, is that ubiquinol binds more tightly to the quinol-oxidizing center of the mutated complexes than ubiquinone, raising its effective redox potential beyond the optimal range for transfer to the [2Fe-2S] cluster. Destabilization of the transient ubisemiquinone state required at the Q(o) center would also inhibit turnover.


FOOTNOTES

*
This work was supported in part by the Oklahoma Center for the Advancement of Science and Technology Grant HN3-008 (to M. W. M.) and National Institutes of Health Grant GM 30721 (to C.-A. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, 246B Noble Research Center, OAES, Oklahoma State University, Stillwater, OK 74078. Tel.: 405-744-9336; Fax: 405-744-7799; mmather@bmb-fs1.biochem.okstate.edu.

(^1)
The abbreviations used are: Q, ubiquinone; EPR, electron paramagnetic resonance; Q(o), ubiquinol-oxidizing center; PAGE, polyacrylamide gel electrophoresis.

(^2)
S. Usui and L. Yu, unpublished results.

(^3)
Y. R. Chen, D. Tolkatchev, and C.-A. Yu, unpublished results.


ACKNOWLEDGEMENTS

We express our thanks to Dr. Yeong-Renn Chen and Tian Hua for providing protein and chromatophore samples and valuable assistance in the analysis thereof. We also thank Dr. Dmitri Tolkachev for help in operation of the EPR spectrometer and interpretation of the EPR data. We are also grateful to Lisa McReynolds for excellent technical assistance and to Dr. Roger Koeppe for critical review of the manuscript.


REFERENCES

  1. Colson, A.-M. (1993) J. Bioenerg. Biomembr. 25, 211-220 [Medline] [Order article via Infotrieve]
  2. degli Esposti, M., de Vries, S., Crimi, M., Ghelli, A., Patarnello, T., and Meyer, A. (1993) Biochim. Biophys. Acta 1143, 243-271 [Medline] [Order article via Infotrieve]
  3. Gennis, R., Barquera, B., Hacker, B., van Doren, S. R., Arnaud, S., Crofts, A. R., Davidson, E., Gray, K. A., and Daldal, F. (1993) J. Bioenerg. Biomembr. 25, 195-209 [Medline] [Order article via Infotrieve]
  4. Link, T. A., Haase, U., and von Jagow, G. (1993) J. Bioenerg. Biomembr. 25, 221-232 [Medline] [Order article via Infotrieve]
  5. Trumpower, B. L. (1990) Microbiol. Rev. 54, 101-129
  6. Trumpower, B. L. (1990) J. Biol. Chem. 265, 11409-11412 [Free Full Text]
  7. Yu, C.-A., and Yu, L. (1993) J. Bioenerg. Biomembr. 23, 259-273
  8. Ljungdahl, P. O., Pennoyer, J. D., Robertson, D. E., and Trumpower, B. L. (1987) Biochim. Biophys. Acta 891, 227-241 [Medline] [Order article via Infotrieve]
  9. Gabellini, N., Bowyer, J. R., Hurt, E., Melandri, B. A., and Hauska, G. (1982) Eur. J. Biochem 126, 105-111 [Abstract]
  10. Yu, L., Mei, Q.-C., and Yu, C.-A. (1984) J. Biol. Chem. 259, 5752-5760 [Abstract/Free Full Text]
  11. McCurley, J. P., Miki, T., Yu, L., and Yu, C.-A. (1990) Biochim. Biophys. Acta 1020, 176-186 [CrossRef][Medline] [Order article via Infotrieve]
  12. Andrews, K. M., Crofts, A. R., and Gennis, R. B. (1990) Biochemistry 29, 2645-2651 [Medline] [Order article via Infotrieve]
  13. Purvis, D. J., Theiler, R., and Niederman, R. A. (1990) J. Biol. Chem. 265, 1208-1215 [Abstract/Free Full Text]
  14. Hauska, G., Nitschke, W., and Herrmann, R. G. (1988) J. Bioenerg. Biomembr. 20, 211-228 [Medline] [Order article via Infotrieve]
  15. He, D.-Y., Yu, L., and Yu, C.-A. (1994) J. Biol. Chem. 269, 2292-2298 [Abstract/Free Full Text]
  16. Vieira, J., and Messing, J. (1983) Gene (Amst.) 19, 254-268
  17. Brosius, J. (1989) DNA (N. Y.) 8, 759-777 [Medline] [Order article via Infotrieve]
  18. Keen, N. T., Tamaki, S., Kobayashi, D., and Trollinger, D. (1988) Gene (Amst.) 70, 191-197 [CrossRef][Medline] [Order article via Infotrieve]
  19. Rott, M. A., Witthuhn, V. C., Schilke, B. A., Soranno, M., Ali, A., and Donohue, T. J. (1993) J. Bacteriol. 175, 358-366 [Abstract]
  20. Simon, R., Priefer, U., and Pühler, A. (1983) Bio/Technology 1, 784-791
  21. Yun, C.-H., Beci, R., Crofts, A. R., Kaplan, S., and Gennis, R. B. (1990) Eur. J. Biochem 194, 399-411 [Abstract]
  22. Titus, D. E. (ed) (1991) Promega Protocols and Applications Guide , 2nd Ed., p. 105, Promega Corporation, Madison, WI
  23. Khosravi, M., Ryan, W., Webster, D. A., and Stark, B. C. (1990) Plasmid 23, 138-143 [Medline] [Order article via Infotrieve]
  24. Sistrom, W. R. (1960) J. Gen. Microbiol. 22, 778-785
  25. Feher, G., and Okamura, M. Y. (1978) in The Photosynthetic Bacteria (Clayton, R. T., and Sistrom, W. R., eds) pp. 349-386, Plenum Publishing Corp., New York
  26. Ward, J. M., and Grinstead, J. (1982) Plasmid 7, 239-250 [Medline] [Order article via Infotrieve]
  27. Hacker, B., Barquera, B., Crofts, A. R., and Gennis, R. B. (1993) Biochemistry 32, 4403-4410 [Medline] [Order article via Infotrieve]
  28. Pemberton, J. M., and Bowen, A. R. S. G. (1981) J. Bacteriol. 147, 110-117 [Medline] [Order article via Infotrieve]
  29. Nano, F. E., and Kaplan, S. (1984) J. Bacteriol. 158, 1094-1103 [Medline] [Order article via Infotrieve]
  30. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  31. Qian, L., and Wilkinson, M. (1991) BioTechniques 10, 736-738 [Medline] [Order article via Infotrieve]
  32. Du, Z., Hood, L., and Wilson, R. K. (1993) Methods Enzymol. 218, 104-121 [Medline] [Order article via Infotrieve]
  33. Yu, L., and Yu, C.-A. (1991) Biochemistry 30, 4934-4939 [Medline] [Order article via Infotrieve]
  34. Atta-Asafo-Adjei, E., and Daldal, F. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 492-496 [Abstract]
  35. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275 [Free Full Text]
  36. Cohen-Bazire, G., Sistrom, W. R., and Stanier, R. Y. (1957) J. Cell. Comp. Physiol. 49, 25-68
  37. Berden, J. A., and Slater, E. C. (1970) Biochim. Biophys. Acta 216, 237-249 [Medline] [Order article via Infotrieve]
  38. Yu, L., Dong, J.-H., and Yu, C.-A. (1986) Biochim. Biophys. Acta 852, 203-211 [CrossRef][Medline] [Order article via Infotrieve]
  39. Redfern, E. R. (1967) Methods Enzymol. 10, 381-384
  40. Kröger, A. (1978) Methods Enzymol. 53, 579-591 [Medline] [Order article via Infotrieve]
  41. Clayton, R. K. (1973) Biochim. Biophys. Acta 75, 312-323
  42. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  43. Schägger, H., and von Jagow, G. (1987) Anal. Biochem. 166, 368-379 [Medline] [Order article via Infotrieve]
  44. Twobin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354 [Abstract]
  45. Haley, P. E., Yu, L., Dong, J.-H., Keyser, G. C., Sanborn, M. R., and Yu, C.-A. (1986) J. Biol. Chem. 261, 14593-14599 [Abstract/Free Full Text]
  46. Chen, Y.-R., Usui, S., Yu, C.-A., and Yu, L. (1994) Biochemistry 33, 10207-10214 [Medline] [Order article via Infotrieve]
  47. Matsuura, K., Bowyer, J. R., Ohnishi, T., and Dutton, P. L. (1983) J. Biol. Chem. 258, 1571-1579 [Abstract/Free Full Text]
  48. Bowyer, J. R., Edwards, C. A., Ohnishi, T., and Trumpower, B. L. (1982) J. Biol. Chem. 257, 8321-8330 [Abstract/Free Full Text]
  49. de Vries, S., Albracht, S. P. J., Berden, J. A., and Slater, E. C. (1982) Biochim. Biophys. Acta 681, 41-45 [Medline] [Order article via Infotrieve]
  50. Seidow, J., Power, S., de la Rosa, F. F., and Palmer, G. (1978) J. Biol. Chem. 253, 2392-2399 [Abstract]
  51. Meinhardt, S. W., Yang, X., Trumpower, B. L., and Ohnishi, T. (1987) J. Biol. Chem. 262, 8702-8706 [Abstract/Free Full Text]
  52. Ding, H., Robertson, D. E., Daldal, F., and Dutton, P. L. (1992) Biochemistry 31, 3144-3158 [Medline] [Order article via Infotrieve]
  53. de Vries, S., Albracht, S. P. J., and Leeuwerik, F. J. (1979) Biochim. Biophys. Acta 546, 316-333 [Medline] [Order article via Infotrieve]
  54. Orme-Johnson, N. R., Hansen, R. E., and Beinert, H. (1974) Biochem. Biophys. Res. Commun. 45, 871-878
  55. Salerno, J. C. (1984) J. Biol. Chem. 259, 2331-2336 [Abstract/Free Full Text]
  56. Tron, T., Crimi, M., Colson, A.-M., and Degli Esposti, M. (1991) Eur. J. Biochem. 199, 753-760 [Abstract]
  57. Yang, X., and Trumpower, B. L. (1986) J. Biol. Chem. 261, 12282-12289 [Abstract/Free Full Text]
  58. Robertson, D. E., Daldal, F., and Dutton, P. L. (1990) Biochem. 29, 11249-11260 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.